ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.80
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
63,625.73
0.33%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX
  6. Oncolytics Biotech Inc (ONC)

  7. Oncolytics Biotech Inc (ONC) News

ONC

Oncolytics Biotech (ONC)

Oncolytics Biotech Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSX:ONC
DateTimeSourceHeadlineSymbolCompany
09/26/20237:00AMPR Newswire (US)THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTSTSX:ONCOncolytics Biotech Inc
06/01/202211:23AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONC.WTTSX:ONCOncolytics Biotech Inc
06/01/202211:21AMPR Newswire (Canada)IIROC Trading Halt - ONC.WTTSX:ONCOncolytics Biotech Inc
01/10/202210:57AMPR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024TSX:ONCOncolytics Biotech Inc
01/10/202210:54AMPR Newswire (US)New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion Market by 2024TSX:ONCOncolytics Biotech Inc
04/09/202110:56AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
04/09/202110:56AMPR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
04/09/202110:53AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
04/09/202110:52AMPR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
02/17/20219:08AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
02/17/20219:07AMPR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
02/17/20218:58AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
02/17/20218:56AMPR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
03/24/20204:06PMPR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
03/24/20202:00PMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
03/24/20201:48PMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
03/24/20201:47PMPR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
03/24/202011:56AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
03/24/202011:54AMPR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
03/24/202011:41AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
03/24/202011:39AMPR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
03/24/20209:33AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - ONCTSX:ONCOncolytics Biotech Inc
03/24/20209:31AMPR Newswire (Canada)IIROC Trade Resumption - ONCTSX:ONCOncolytics Biotech Inc
03/24/20209:28AMPR Newswire (Canada)Suspension de la négociation par l'OCRCVM - ONCTSX:ONCOncolytics Biotech Inc
03/24/20209:26AMPR Newswire (Canada)IIROC Trading Halt - ONCTSX:ONCOncolytics Biotech Inc
12/27/20176:00AMPR Newswire (US)Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...TSX:ONCOncolytics Biotech Inc
12/27/20176:00AMPR Newswire (Canada)Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patien...TSX:ONCOncolytics Biotech Inc
12/05/20176:00AMPR Newswire (US)Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...TSX:ONCOncolytics Biotech Inc
12/05/20176:00AMPR Newswire (Canada)Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic B...TSX:ONCOncolytics Biotech Inc
12/04/20176:00AMPR Newswire (US)Oncolytics Biotech® to Present at the Oncolytic Virotherapy SummitTSX:ONCOncolytics Biotech Inc
 Showing the most relevant articles for your search:TSX:ONC

Your Recent History

USOTC
VXIT
Virexit Technologies (PK)
NYSE
AMC
AMC Entertainment
USOTC
KEGS
1812 Brewing (PK)
NASDAQ
AMRN
Amarin
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
AABB
Asia Broadband (PK)
USOTC
INND
Innerscope Hearing Techn... (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
BEGI
BlackStar Enterprise (PK)
USOTC
SPZI
Spooz (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
COIN
SHIBUSD
SHIBA INU
NASDAQ
NB
NioCorp Developments
USOTC
FNMA
Fannie Mae (QB)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved